Nektar Therapeutics (NKTR) stock
NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 9/30
$35.91−0.53 (-1.45%)
Close on Nov 17, 2026Market cap $1.23BP/E –Yield –
Nektar Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Nektar Therapeutics's EV/EBITDA was 5.4× on Jul 31, 2019, against 28.3× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jul 31, 2019 | 5.4× | −0.1 |
| 2018 | Dec 31, 2018 | 5.5× | −22.8 |
| 2015 | Oct 30, 2015 | 28.3× | – |
See a number that looks wrong?